Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
Listed Suppliers
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Acepromazine
2. Acetazine
3. Acetopromazine
4. Acetylpromazine
5. Calmivet
6. Maleate, Acepromazine
7. Plegicil
8. Vetranquil
1. 3598-37-6
2. Anatran
3. Sedalin
4. Soprontin
5. Acetopromazine Maleate Salt
6. Acepromazine Monomaleate
7. Acetopromazine Maleate
8. 37862hp2om
9. Acepromazine Hydrogen Maleate
10. Nsc-264522
11. Acetylpromazine Maleate (1:1)
12. 2-acetyl-10-(3-(dimethylamino)propyl)phenothiazine, Maleate
13. Acepromazine D6 Maleate
14. 10-(3-(dimethylamino)propyl)phenothiazin-2-yl Methyl Ketone Maleate (1:1)
15. Dsstox_cid_27763
16. Dsstox_rid_82540
17. Ethanone, 1-(10-(3-(dimethylamino)propyl)-10h-phenothiazin-2-yl)-, (z)-2-butenedioate (1:1)
18. Dsstox_gsid_47783
19. A 23051
20. Notensil Maleate
21. Maleate Acide De L'acetyl 3-dimethylamino 3-propyl-10-phenothiazine
22. Sr-05000001648
23. Ncgc00016634-01
24. Cas-3598-37-6
25. Nsc 264522
26. Acepromazine Maleate [usan]
27. Unii-37862hp2om
28. Acepromazine Maleate [usan:usp]
29. Prestwick_888
30. Einecs 222-748-9
31. Mfcd00082473
32. 1-(10-(3-(dimethylamino)propyl)-10h-phenothiazin-2-yl)ethanone Maleate
33. (z)-but-2-enedioic Acid;1-[10-[3-(dimethylamino)propyl]phenothiazin-2-yl]ethanone
34. Acepromazinemaleate
35. Acepromazine Hydrogenmaleate
36. Acepromazine Maleate (usp)
37. Schembl204733
38. Chembl1883146
39. Dtxsid6047783
40. Acepromazine Maleate [mi]
41. 2-acetyl-10-(3-dimethylaminopropyl)phenothiazine Maleate Salt
42. Hms1569d14
43. Hms2093n15
44. Hms2096d14
45. Hms3263n18
46. Hms3713d14
47. Pharmakon1600-01505498
48. Phenothiazine, 2-acetyl-10-(3-(dimethylamino)propyl)-, Maleate
49. Tox21_110536
50. Tox21_501268
51. Acepromazine Maleate [mart.]
52. Nsc760058
53. Acepromazine Maleate [usp-rs]
54. Acepromazine Maleate [who-dd]
55. Akos015855868
56. Maleate Acide De L'acetyl 3-dimethylamino 3-propyl-10-phenothiazine [french]
57. Tox21_110536_1
58. Acepromazine Maleate, >=98% (hplc)
59. Ccg-213470
60. Ds-9727
61. Nsc-760058
62. Acepromazine Maleate [green Book]
63. Ncgc00016634-04
64. Ncgc00261953-01
65. Acepromazine Maleate [usp Monograph]
66. Cs-0013292
67. Acepromazine Maleate 100 Microg/ml In Ethanol
68. D02604
69. 9-oxo-9h-thioxanthene-3-carboxylicacid&
70. A874474
71. A935720
72. Sr-05000001648-1
73. Sr-05000001648-2
74. Q27256656
75. Acepromazine Maleate, United States Pharmacopeia (usp) Reference Standard
76. Ketone, 10-(3-(dimethylamino)propyl)phenothiazin-2-yl Methyl, Maleate (1:1)
77. (2z)-but-2-enedioic Acid; 1-{10-[3-(dimethylamino)propyl]-10h-phenothiazin-2-yl}ethan-1-one
78. 115120-92-8
Molecular Weight | 442.5 g/mol |
---|---|
Molecular Formula | C23H26N2O5S |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 7 |
Exact Mass | 442.15624311 g/mol |
Monoisotopic Mass | 442.15624311 g/mol |
Topological Polar Surface Area | 123 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 533 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
Dopamine Antagonists
Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5177
Submission : 1983-11-04
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7803
Submission : 1988-11-28
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?